Warren Buffett is Decreasing Stakes in These 3 Stocks
In this article, we discuss the 3 stocks that Warren Buffett is decreasing stakes in.
Posts Tagged ‘NASDAQ:RPRX’
10 Dividend Stocks to Buy According to Andreas Halvorsen’s Viking Global
In this article, we discuss the dividend stocks to buy according to Andreas Halvorsen's Viking Global.
Hedge Fund and Insider Trading News: Bill Ackman, Ray Dalio, John Paulson, Citadel LLC, Tiger Global Management, Royalty Pharma PLC (RPRX), Nicolet Bankshares Inc (NCBS), and More
Billionaire hedge fund manager Bill Ackman asserted on Tuesday that the United States Federal Reserve needs to tackle inflation in an aggressive manner or face a market crash ...
Warren Buffett is Selling These 3 Stocks in 2022
In this article, we discuss 3 stocks that Warren Buffett is selling in 2022.
5 Best Dividend Stocks According to Andreas Halvorsen’s Viking Global
In this article, we discuss the 5 best dividend stocks according to Andreas Halvorsen's Viking Global.
Warren Buffett Is Selling These 10 Stocks
In this article, we discuss the 10 stocks that Warren Buffett is selling.
10 Best Healthcare Stocks To Buy In 2022
In this article, we discuss 10 best healthcare stocks to buy in 2022.
Royalty Pharma Plc (RPRX) Fell Out Of Favor With Hedge Funds
After several tireless days we have finished crunching the numbers from nearly 900 13F filings issued by the elite hedge funds and other investment firms that we track at Insider...
Harvard University Stock Portfolio: Top 5 Picks
In this article, we discuss the top 5 picks in Harvard University's Stock portfolio.
Hedge Funds Are Crazy About Royalty Pharma Plc (RPRX)
Before we spend countless hours researching a company, we like to analyze what insiders, hedge funds and billionaire investors think of the stock first.
Billionaire Steve Cohen’s Top 10 Small-Cap Stock Picks
In this article we presented billionaire Steve Cohen's top 10 small-cap stock picks.
Billionaire Steve Cohen’s Top 5 Small-Cap Stock Picks
In this article we discuss the billionaire Steve Cohen's top 5 small-cap stock picks.
Is RPRX A Good Stock To Buy Now?
Before we spend countless hours researching a company, we like to analyze what insiders, hedge funds and billionaire investors think of the stock first.
Hedge Fund and Insider Trading News: Waratah Capital Advisors, Dalton Investments, AQR Capital Management, CARN Capital, BrightSphere Investment Group Inc (BSIG), Dave & Buster’s Entertainment Inc (PLAY), and More
Waratah Capital Advisors has launched the firm's second liquid alternative mutual fund, the Waratah Alternative ESG (AESG) Fund.
Why Twitter, AMD and 2 Other Stocks Are in the Red Today, While Repros is Surging
It's profit taking day for many investors, as all three major indexes are modestly lower. In late-afternoon trading, both the Dow and the S&P are off by 0.24%, while the Nasdaq...
Here’s What Latest Data Could Mean For Repros Therapeutics Inc (RPRX)
Repros Therapeutics Inc (NASDAQ:RPRX) just put out data from its phase II in moderate to severe endometriosis, and the company has gained close to 17% on the data.
Be Wary of These Five Tanking Stocks Today, Office Depot Among Them
Although all three indexes are well in the green and the Dow Jones is above 18,000 with this quarter's earnings season being relatively quiet and the results less dire than had...
Why Disney (DIS), Amedica (AMDA), Cvent (CVT), UniPixel (UNXL), and Repros Therapeutics (RPRX) Are Spiking Today
After the OPEC countries participating in the Doha meeting this weekend failed to reach a deal to limit oil production, crude prices fell heavily on Monday.
What’s the Deal With These 5 Stocks on the Move Today?
With earnings season now in full swing, the Dow and S&P 500 are each slightly in the red as investors weigh various bits of macro-economic data and different earnings reports.
Why Repros Therapeutics Inc (RPRX) Was One Of Black Friday’s Biggest Gainers
Shares of Repros Therapeutics Inc (NASDAQ:RPRX) ended up by 45.14% during today's truncated Black Friday trading session, following the Thanksgiving holiday.
RA Capital Discloses New Passive Stake in Repros Therapeutics Inc (RPRX)
RA Capital Management, managed by Peter Kolchinsky, has revealed a new position in Repros Therapeutics Inc (NASDAQ:RPRX).
11 Insider Trades To Keep An Eye On
Insider buying activity has been shown to generate annual outperformance of about 7 percentage points, according to multiple empirical studies.
Repros Therapeutics: New Drug Development Stimulates Insider Trading
Repros Therapeutics new drug: Insider Katherine Anderson, Chief Financial Officer at Repros Therapeutics Inc (NASDAQ:RPRX), purchased 1,000 shares of common stock last week at...
Safeway Inc. (SWY), DaVita HealthCare Partners Inc (DVA), Repros Therapeutics Inc (RPRX): Today’s Three Best Stocks
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis...
Here is What Hedge Funds Think About Sunesis Pharmaceuticals, Inc. (NASDAQ:SNSS)
At the moment, there are tons of metrics shareholders can use to monitor their holdings. A couple of the most under-the-radar are hedge fund and insider trading sentiment.
Repros Therapeutics Inc (RPRX): Hedge Funds Are Bullish and Insiders Are Undecided, What Should You Do?
To many of your peers, hedge funds are viewed as bloated, outdated financial vehicles of a forgotten age.
Do Hedge Funds and Insiders Love Cerus Corporation (CERS)?
In today’s marketplace, there are a multitude of indicators market participants can use to watch stocks.
Should You Buy XOMA Corp (XOMA)?
In the eyes of most stock holders, hedge funds are seen as unimportant, old investment vehicles of yesteryear.
Repros Therapeutics Inc (RPRX): Are Hedge Funds Right About This Stock?
Repros Therapeutics Inc (NASDAQ:RPRX) was in 15 hedge funds' portfolio at the end of the first quarter of 2013.
Hedge Funds Are Betting On Cerus Corporation (CERS)
To most traders, hedge funds are viewed as slow, outdated investment tools of the past.
Hedge Funds Are Betting On Repros Therapeutics Inc (RPRX)
Is Repros Therapeutics Inc (NASDAQ:RPRX) worth your attention right now? Prominent investors are turning bullish.
Biogen Idec Inc. (BIIB), United Therapeutics Corporation (UTHR), Repros Therapeutics Inc (RPRX): This Week in Biotech
With the SPDR S&P Biotech (ETF) (NYSEARCA:XBI) Index up 25% over the trailing-12-month period, it's evident that investment dollars are willingly flowing into the biotech sector...
This Week in Biotech: VIVUS, Inc. (VVUS), Roche Holdings Ltd-Spons Adr (RHHBY)
With the SPDR S&P Biotech Index up 25% over the trailing-12-month period, it's evident that investment dollars are willingly flowing into the biotech sector.
